INS and Hypoglycemia: For example, sulphonylurea drugs were in use for many decades before the identification of the KATP channel as their major site of action in the β-cell, but this mode of action explains how sulphonylureas can stimulate insulin secretion from glucose-unresponsive β-cells and why sulphonylureas can induce hypoglycemia.